Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection

Knolle, 2001, Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells, Trends Immunol, 22, 432, 10.1016/S1471-4906(01)01957-3

Winau, 2007, Starring stellate cells in liver immunology, Curr Opin Immunol, 20, 68, 10.1016/j.coi.2007.10.006

Limmer, 2000, Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance, Nat Med, 6, 1348, 10.1038/82161

Wu, 2007, Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice, HEPATOLOGY, 46, 1769, 10.1002/hep.21897

Klein, 2005, The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury, J Clin Invest, 115, 860, 10.1172/JCI23640

Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol, 5, 215, 10.1038/nri1573

Kakimi, 2001, Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver, J Immunol, 167, 6701, 10.4049/jimmunol.167.12.6701

Isogawa, 2005, Toll-like receptor signaling inhibits hepatitis B virus replication in vivo, J Virol, 79, 7269, 10.1128/JVI.79.11.7269-7272.2005

Guidotti, 1999, Viral clearance without destruction of infected cells during acute HBV infection, Science, 284, 825, 10.1126/science.284.5415.825

Wieland, 2004, Genomic analysis of the host response to hepatitis B virus infection, Proc Natl Acad Sci U S A, 101, 6669, 10.1073/pnas.0401771101

van Dam, 1993, Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding, J Biol Chem, 268, 15285, 10.1016/S0021-9258(18)82467-X

Fischer, 1997, I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion, Nat Biotechnol, 15, 142, 10.1038/nbt0297-142

Schulze-Bergkamen, 2003, Primary human hepatocytes - a valuable tool for investigation of apoptosis and hepatitis B virus infection, J Hepatol, 38, 736, 10.1016/S0168-8278(03)00120-X

Untergasser, 2006, Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection, HEPATOLOGY, 43, 539, 10.1002/hep.21048

Protzer, 2007, Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection, Gastroenterology, 133, 1156, 10.1053/j.gastro.2007.07.021

Quasdorff, 2008, A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation, Cell Microbiol, 10, 1478, 10.1111/j.1462-5822.2008.01141.x

Torre, 1994, Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis, Clin Infect Dis, 18, 194, 10.1093/clinids/18.2.194

Visvanathan, 2007, Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein, HEPATOLOGY, 45, 102, 10.1002/hep.21482

Fisicaro, 2009, Early kinetics of innate and adaptive immune responses during hepatitis B virus infection, Gut, 58, 974, 10.1136/gut.2008.163600

Wu, 2008, Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells, HEPATOLOGY, 10.1016/S0168-8278(08)60583-8

Cheng, 2005, Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1, J Hepatol, 43, 465, 10.1016/j.jhep.2005.02.033

Kucharczak, 2003, To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis, Oncogene, 22, 8961, 10.1038/sj.onc.1207230

Kovalovich, 2001, Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL, J Biol Chem, 276, 26605, 10.1074/jbc.M100740200

Taub, 2003, Hepatoprotection via the IL-6/Stat3 pathway, J Clin Invest, 112, 978, 10.1172/JCI19974

Guidotti, 1996, Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes, Immunity, 4, 25, 10.1016/S1074-7613(00)80295-2

Pasquetto, 2002, Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures, J Virol, 76, 5646, 10.1128/JVI.76.11.5646-5653.2002

Biermer, 2003, Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB, J Virol, 77, 4033, 10.1128/JVI.77.7.4033-4042.2003

Gilles, 1992, Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice, J Virol, 66, 3955, 10.1128/JVI.66.6.3955-3960.1992

Waris, 2002, Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function, J Virol, 76, 2721, 10.1128/JVI.76.6.2721-2729.2002

Galun, 2000, Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo, Virology, 270, 299, 10.1006/viro.2000.0210

Heinz, 2001, Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection, J Viral Hepatol, 8, 186, 10.1046/j.1365-2893.2001.00281.x

Raney, 1990, Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines, J Virol, 64, 2360, 10.1128/JVI.64.5.2360-2368.1990

Raney, 1997, Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter, J Virol, 71, 1058, 10.1128/JVI.71.2.1058-1071.1997

Yu, 2003, Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1, J Virol, 77, 2489, 10.1128/JVI.77.4.2489-2499.2003

Ying, 2007, Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue, Proc Natl Acad Sci U S A, 104, 8526, 10.1073/pnas.0609883104

Dumortier, 2005, Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice, Gene Ther, 12, 668, 10.1038/sj.gt.3302449

Wieland, 2005, Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids, Proc Natl Acad Sci U S A, 102, 9913, 10.1073/pnas.0504273102

Heinrich, 2003, Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochem J, 374, 1, 10.1042/bj20030407

Zheng, 2003, Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway, J Virol, 77, 7707, 10.1128/JVI.77.14.7707-7712.2003